Four Years Since COVID-19 Day Zero: A Time to Evaluate Past and Future Pandemic Control Policies and Practices in Sub-Saharan Africa?
Obinna Oleribe,Andrew Taylor-Robinson,Okey Nwanyanwu,Marsha Morgan,Simon Taylor-Robinson
DOI: https://doi.org/10.2147/rmhp.s449701
2024-03-06
Risk Management and Healthcare Policy
Abstract:Obinna O Oleribe, 1, 2 Andrew W Taylor-Robinson, 3, 4 Okey C Nwanyanwu, 5 Marsha Y Morgan, 6 Simon D Taylor-Robinson 7, 8 1 Office of the Director-General, Nigerian Institute for Medical Research, Lagos, Nigeria; 2 Best Health Consult Limited Liability Company, Orange, CA, USA; 3 College of Health Sciences, VinUniversity, Hanoi, Vietnam; 4 Center for Global Health, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA; 5 Fast Forward Africa Limited Liability Company, Austin, TX, USA; 6 Division of Medicine, Royal Free Campus, University College London, London, UK; 7 Departments of Medicine & Public Health, Busitema University, Mbale, Uganda; 8 Department of Surgery and Cancer, Imperial College London, St Mary's Hospital Campus, London, UK Correspondence: Simon D Taylor-Robinson, Email Four years after the first case of COVID-19, the world is still determining how best to prevent and control the long-term effects of SARS-CoV-2 infection. Non-pharmaceutical interventions (NPIs) were employed at the start of the pandemic as the only available options, prior to effective vaccines and antiviral agents. The World Health Organization recommended dual vaccination for 70% worldwide as the threshold for a return to "normal" community life. Immunization rates needed to increase in all global regions, irrespective of socioeconomic status, necessitating more equitable access. During the pandemic, wealthier countries hoarded vaccine supplies even when their citizens were immunized. This highlights the already enormous difficulties in healthcare provision faced by low-income sub-Saharan African countries, which remain at risk as industrialized nations have progressed to a post-pandemic era. Thus, in addition to redoubling vaccination efforts public health policymakers should consider ongoing and future use of NPIs. In this narrative account, we advocate that various NPI practices should not be shelved; rather, more research is needed to evaluate their impact in parallel with booster vaccination. This especially applies to so-called "long COVID". Lessons learned from implementing best practices in resource-limited settings should be incorporated into preparedness guidelines for future infectious disease outbreaks. Keywords: sub-Saharan Africa, COVID-19, health inequality, non-pharmaceutical interventions, pandemic, vaccination Much has been written on the global pandemic caused by severe acute respiratory syndrome coronavirus (SARS-CoV)-2 infection. 1–4 SARS-CoV-2, in common with two other pathogenic human respiratory coronaviruses, SARS-CoV and MERS-CoV, tends to cause symptoms at the severe end of the respiratory disease spectrum. 5,6 By comparison, infections with four other coronaviruses, HKU1, NL63, 229E and OC43, generally produce much milder symptoms, often referred to as the "common cold". 7 With the initial emergence of human SARS-CoV-2 infections in December 2019, subsequently termed "coronavirus disease 2019" (COVID-19), the first response of governments around the world was to try to prevent and control viral transmission through public health interventions. 8 Efforts escalated as the virus spread from China to Western Europe and North America in January 2020, with African cases following shortly afterwards. 9 When the World Health Organization (WHO) declared COVID-19 to be a "public health emergency of international concern" on January 30, 2020, 10 and then on March 11, 2020, confirmed that the world was facing a pandemic, 11 the global strategy focused first on disease prevention and later on accelerated development of vaccines and antiviral agents. 6 In the interim, most countries adopted hastily arranged interventions, whereby national borders were closed, air travel was suspended, schools and offices were shut, and remote working and learning were promoted. 12,13 The introduction of personal protective measures meant that people across sub-Saharan Africa and other parts of the world were asked to wear masks, wash their hands frequently or to use hand sanitizers, maintain social distancing, stay at home wherever possible, avoid hand-to-face contact and minimize socialization with others, including shaking hands and other more intimate greetings. 14–19 In addition, screening policies were implemented in Africa using newly developed viral antigen testing; exposed individuals were required to quarantine and those testing positive were asked to self-isolate if it was clinically safe to do so. 7,15,17 Those who developed more severe symptoms were either treated in isolation centres or referred to public and pr -Abstract Truncated-
health care sciences & services,health policy & services